These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23850849)

  • 61. Evaluation of left ventricular function by tissue Doppler and speckle-derived strain rate echocardiography after percutaneous ductus closure.
    Amoogzar H; Shakiba AM; Derakhshan D; Ajami G; Cheriki S; Borzouee M; Edraki MR; Mehdizadegan N
    Pediatr Cardiol; 2015 Jan; 36(1):219-25. PubMed ID: 25107547
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Subclinical Cardiac Dysfunction in Childhood Cancer Survivors on 10-Years Follow-Up Correlates With Cumulative Anthracycline Dose and Is Best Detected by Cardiopulmonary Exercise Testing, Circulating Serum Biomarker, Speckle Tracking Echocardiography, and Tissue Doppler Imaging.
    Wolf CM; Reiner B; Kühn A; Hager A; Müller J; Meierhofer C; Oberhoffer R; Ewert P; Schmid I; Weil J
    Front Pediatr; 2020; 8():123. PubMed ID: 32296665
    [No Abstract]   [Full Text] [Related]  

  • 63. Growth Differentiation Factor-15 Level and Tissue Doppler Echocardiography as a Tool in Identification of Cardiac Effects in the Children with Type 1 Diabetes Mellitus.
    Uysal C; Arslan D; Buyukinan M; Gederet YT; Vatansev H; Ozcelik HS
    Exp Clin Endocrinol Diabetes; 2021 Aug; 129(8):574-580. PubMed ID: 31426113
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of cardiotoxicity by tissue Doppler imaging in childhood leukemia survivors treated with low-dose anthracycline.
    Bayram C; Çetin İ; Tavil B; Yarali N; Ekici F; Isık P; Tunc B
    Pediatr Cardiol; 2015 Apr; 36(4):862-6. PubMed ID: 25577226
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Late cardiotoxic effects of anthracycline chemotherapy in childhood malignancies.
    Roodpeyma S; Moussavi F; Kamali Z
    J Pak Med Assoc; 2008 Dec; 58(12):683-7. PubMed ID: 19157322
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors.
    Hudson MM; Rai SN; Nunez C; Merchant TE; Marina NM; Zalamea N; Cox C; Phipps S; Pompeu R; Rosenthal D
    J Clin Oncol; 2007 Aug; 25(24):3635-43. PubMed ID: 17704413
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Association between right ventricular dysfunction and restrictive lung disease in childhood cancer survivors as measured by quantitative echocardiography.
    Patel A; Weismann C; Weiss P; Russell K; Bazzy-Asaad A; Kadan-Lottick NS
    Pediatr Blood Cancer; 2014 Nov; 61(11):2059-64. PubMed ID: 25130668
    [TBL] [Abstract][Full Text] [Related]  

  • 68. High-sensitive cardiac troponin-I facilitates timely detection of subclinical anthracycline-mediated cardiac injury.
    Jones M; O'Gorman P; Kelly C; Mahon N; Fitzgibbon MC
    Ann Clin Biochem; 2017 Jan; 54(1):149-157. PubMed ID: 27170025
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cardiac Surveillance for Early Detection of Late Subclinical Cardiac Dysfunction in Childhood Cancer Survivors After Anthracycline Therapy.
    Sofia R; Melita V; De Vita A; Ruggiero A; Romano A; Attinà G; Birritella L; Lamendola P; Lombardo A; Lanza GA; Delogu AB
    Front Oncol; 2021; 11():624057. PubMed ID: 34055601
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Novel approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer: a multi-centre observational study.
    Skitch A; Mital S; Mertens L; Liu P; Kantor P; Grosse-Wortmann L; Manlhiot C; Greenberg M; Nathan PC
    BMC Cancer; 2017 Aug; 17(1):519. PubMed ID: 28774277
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cardiac dysfunction in cancer survivors unmasked during exercise.
    Kearney MC; Gallop-Evans E; Cockcroft JR; Stöhr EJ; Lee E; Backx K; Haykowsky M; Yousef Z; Shave R
    Eur J Clin Invest; 2017 Mar; 47(3):213-220. PubMed ID: 28036108
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The relationship between plasma hyaluronan levels and anthracycline-related cardiotoxicity in breast cancer patients.
    Inanc MT; Karadavut S; Aytekin M; Duran AO; Derya M; Akpek M; Sahin O; Kalay N; Karaca H; Ozkan M; Inanc M
    Int J Cardiol; 2016 Sep; 218():246-251. PubMed ID: 27236123
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Late cardiac effect of anthracycline therapy in physically active breast cancer survivors - a prospective study.
    Nagy AC; GulAcsi-BArdos P; CserEp Z; Hangody L; Forster T
    Neoplasma; 2017; 64(1):92-100. PubMed ID: 27881009
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.
    Blanco JG; Sun CL; Landier W; Chen L; Esparza-Duran D; Leisenring W; Mays A; Friedman DL; Ginsberg JP; Hudson MM; Neglia JP; Oeffinger KC; Ritchey AK; Villaluna D; Relling MV; Bhatia S
    J Clin Oncol; 2012 May; 30(13):1415-21. PubMed ID: 22124095
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anthracycline-induced cardiomyopathies evaluated by tissue Doppler tracking system and strain rate imaging.
    Takenaka K; Kuwada Y; Sonoda M; Uno K; Asakawa M; Sakurai S; Takahashi T; Sasaki K; Matsuzaki M; Kikuchi A; Amagai R; Furudate N; Nagai R
    J Cardiol; 2001; 37 Suppl 1():129-32. PubMed ID: 11433816
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Torsion analysis in the early detection of anthracycline-mediated cardiomyopathy.
    Motoki H; Koyama J; Nakazawa H; Aizawa K; Kasai H; Izawa A; Tomita T; Miyashita Y; Kumazaki S; Takahashi M; Ikeda U
    Eur Heart J Cardiovasc Imaging; 2012 Jan; 13(1):95-103. PubMed ID: 21926409
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Can comprehensive echocardiographic evaluation provide an advantage to predict anthracycline-induced cardiomyopathy?
    Erdoğan D; Yücel H; Alanoğlu EG; Uysal BA; Koçer M; Ozaydın M; Doğan A
    Turk Kardiyol Dern Ars; 2011 Dec; 39(8):646-53. PubMed ID: 22257802
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Automatic border detection identifies subclinical anthracycline cardiotoxicity in children with malignancy.
    Hashimoto I; Ichida F; Miura M; Okabe T; Kanegane H; Uese K; Hamamichi Y; Misaki T; Koizumi S; Miyawaki T
    Circulation; 1999 May; 99(18):2367-70. PubMed ID: 10318655
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mitral regurgitation after anthracycline treatment for childhood malignancy.
    Allen J; Thomson JD; Lewis IJ; Gibbs JL
    Heart; 2001 Apr; 85(4):430-2. PubMed ID: 11250971
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Discriminative ability of conventional echocardiography and tissue Doppler imaging techniques for the detection of subclinical cardiotoxic effects of treatment with anthracyclines.
    Kapusta L; Thijssen JM; Groot-Loonen J; van Druten JA; Daniëls O
    Ultrasound Med Biol; 2001 Dec; 27(12):1605-14. PubMed ID: 11839405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.